CCE Advisory Council

Myles A Brown, MD, obtained his undergraduate degree in Biology from Yale University and his M.D. from the Johns Hopkins University School of Medicine. He completed training in Internal Medicine at the Brigham and Women’s Hospital while doing research with David Livingston at the Dana-Farber. He went on to complete training in Medical Oncology at the Dana-Farber and postdoctoral research with Phillip Sharp at MIT. Following the completion of his training he joined the faculty of the Dana-Farber and Harvard Medical School. From 2002-2010 he served as Chief of the Division of Molecular and Cellular Oncology at the Dana-Farber. In 2010 together with Shirley Liu he founded the Center for Functional Cancer Epigenetics at the Dana-Farber.

Frank Laukien, PhD, has served as Chairman, President, and CEO of Bruker Corporation since 1991 and is its largest stockholder. He also sits on the boards of several Bruker subsidiaries and previously chaired ALDA from 2002 to 2003. Dr. Laukien holds a BS in physics from MIT and a PhD in chemical physics from Harvard. He has held advisory and trustee roles at MIT and the Rivers School, and was elected a senator of acatech in 2017. In 2021, he was appointed a Visiting Scholar at Harvard. Dr. Laukien brings to the Board deep operational insight, scientific expertise, and extensive experience in global business strategy and leadership.

Michael Yaffe, MD, PhD, is the David H. Koch Professor of Science at MIT and Director of the MIT Center for Precision Cancer Medicine. He is also an attending surgeon and intensivist at Beth Israel Deaconess Medical Center. Yaffe earned his MD-PhD from Case Western Reserve and completed surgical training at Harvard-affiliated hospitals. A former HHMI and Burroughs-Wellcome Fellow, he did postdoctoral work with Lewis Cantley. He is Editor-in-Chief of Science Signaling and serves on several editorial boards. A retired U.S. Army Reserve Colonel and Afghanistan veteran, Yaffe co-founded several biotech companies including Merrimack Pharmaceuticals and serves as an advisor to multiple others.